| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2.07M | 100% | $1.45 | +$3M |
| Sells | 0 | ||||
| Net | +1 | +2.07M | 100% | +$3M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sands Capital Life Sciences Pulse Fund II, L.P. | 10%+ Owner | $18.9M | +$3M | +18.9% | Nov 21, 2025 |
| Roberto Francesco Bellini | Director | $2M | Jun 30, 2025 | ||
| Christopher Cabell | President & Head of R&D | $1.7M | Feb 21, 2025 | ||
| Vincent Aurentz | Director | $1.29M | Jun 30, 2025 | ||
| Amit Munshi | Director | $709K | Jun 30, 2025 | ||
| Arvind Kush | Director | $199K | Jun 30, 2025 | ||
| Joseph Frattaroli | Cheif Financial Officer | $38.5K | Mar 1, 2023 | ||
| David McIntyre | Chief Financial Officer | $14.1K | Apr 14, 2025 | ||
| Dennis N. Berman | Director | Jun 30, 2025 | |||
| Roy Lester Freeman | Director | Feb 14, 2025 | |||
| Gisele Dion | Director | Jul 16, 2024 | |||
| Milton H. Werner | President and CEO, Director | Jan 21, 2025 | |||
| Elizabeth G. O'Farrell | Director | Jun 24, 2022 | |||
| Mark T. Iwicki | Chief Executive Officer, Director | Feb 21, 2025 | |||
| David Canner | Director | Jun 30, 2025 | |||
| Garth Lees-Rolfe | Chief Financial Officer | Jan 21, 2025 | |||
| Paul C. Grint | Director | Jul 16, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|